Cabot Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CBT research report →
Range $90 – $100
Price Chart
About the company
Cabot Corporation operates as a specialty chemicals and performance materials company. It operates through two segments, Reinforcement Materials and Performance Chemicals. The company offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
- CEO
- Erica J. McLaughlin
- IPO
- 1980
- Employees
- 4,064
- HQ
- Boston, MA, US
Get TickerSpark's AI analysis on CBT
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $3.62B
- P/E
- 17.19
- Fwd P/E
- 10.63
- PEG
- -0.53
- P/S
- 0.96
- P/B
- 2.21
- EV/EBITDA
- 6.60
- Div Yield
- 2.63%
- Gross Margin
- 21.79%
- Op Margin
- 12.95%
- Net Margin
- 5.69%
- ROE
- 13.35%
- ROIC
- 8.82%
Latest fiscal year · YoY change
- Revenue
- $3.74B+0.8%
- Gross Profit
- $809.00M-13.9%
- Op Income
- $477.00M
- Net Income
- $213.00M-35.6%
- EPS
- $4.10-32.5%
- OCF Growth
- -36.7%
- FCF Growth
- -45.3%
- 52W High
- $94.53
- 52W Low
- $59.34
- 50D MA
- $75.20
- 200D MA
- $79.54
- Beta
- 0.82
- RSI (14)
- 47
- Avg Volume
- 390.81K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Cabot closed fiscal 2026 with solid EPS, cash generation, and margin expansion in Performance Chemicals, while Reinforcement Materials stayed pressured by weak tire demand and customer contract resets.· November 3, 2026
- Adjusted EPS was $1.61 in Q4 and $6.42 for fiscal 2026.
- Q4 cash flow from operations was $143 million; full-year operating cash flow was $421 million.
- Performance Chemicals was the standout, with Q4 EBIT up 43% to $60 million and EBITDA margin up to 24%.
- Reinforcement Materials EBIT fell to $87 million in Q4 from $119 million a year ago, mainly due to lower gross profit per ton and mix.
- Fiscal 2027 EPS guidance is $6.15-$6.75, with battery materials EBITDA expected to be in the high $40 million range and company capex at $200 million-$230 million.
Cabot reported adjusted EPS of $1.61 in the fourth quarter and $6.42 for the full year. Q4 segment EBIT was $87 million for Reinforcement Materials and $60 million for Performance Chemicals; full-year segment EBIT was $379 million and $235 million, respectively. Q4 cash flow from operations was $143 million, discretionary free cash flow was $117 million, and full-year operating cash flow was $421 million. For fiscal 2027, management guided adjusted EPS to $6.15-$6.75, operating tax rate to 28%-30%, and capex to $200 million-$230 million. Battery materials EBITDA is expected to rise from $43 million in fiscal 2026 to the high $40 million range in fiscal 2027, with more meaningful growth expected in 2028 as new capacity comes online.
Erica McLaughlin’s tone was confident and continuity-focused in her first call as CEO. She emphasized that Cabot will keep its balanced capital allocation framework, protect its investment-grade profile, and invest behind growth opportunities while staying disciplined. Strategically, she highlighted battery materials, electronics, and targeted capacity investments as the main long-term growth drivers, while acknowledging that 2027 is an investment year, especially in battery materials. She also stressed that the company is still working through a mixed and dynamic environment, particularly in Reinforcement Materials.
Steve Delahunt emphasized cash generation, balance-sheet strength, and margin performance. He noted $143 million of operating cash flow in Q4, $117 million of discretionary free cash flow, $55 million of capex in the quarter, and $207 million for the year, ending fiscal 2026 with $254 million of cash, about $1.3 billion of debt, and $1.5 billion of liquidity. He also pointed to Reinforcement Materials EBIT of $87 million versus $119 million a year ago, with 18% EBITDA margin, while Performance Chemicals delivered $60 million of EBIT and 24% EBITDA margin. He framed the company as entering fiscal 2027 with a solid investment-grade credit profile and flexibility to keep investing and returning cash.
Analysts focused on tire contract negotiations, the impact of energy and freight costs, and whether lower tire imports in North America and Europe are improving Reinforcement Materials demand. Management said about a third of calendar 2027 tire negotiations are complete, but it is too early to characterize final outcomes, and the current guidance range reflects different possible contract outcomes. On costs, Erica said freight/logistics are not a major issue because most Reinforcement Materials products move regionally, while higher energy and feedstock costs are largely managed through pricing, though they do affect working capital. She also said lower oil would not materially hurt profitability because pricing resets to preserve dollar margin per ton, though it would affect percent margins and eventually release working capital.
Cabot showed clear earnings momentum in Performance Chemicals, where higher volumes, favorable mix, and lower costs drove double-digit earnings and margin expansion. Management is also constructive on battery materials, citing $43 million of EBITDA in fiscal 2026, high-$40 million EBITDA expected in 2027, and stronger growth in 2028 as new capacity starts contributing. The company ended the year with strong liquidity and said it has room to keep funding growth while returning cash to shareholders.
Reinforcement Materials remains under pressure from flat global tire production, weak regional demand, and customer contract outcomes that hurt year-over-year comparisons. Management said 2027 negotiations are still underway and that the full-year EPS range incorporates a wide set of possible outcomes, especially in Reinforcement Materials. Battery materials also becomes a drag on near-term earnings in 2027 because it is an investment year before the new capacity translates into more meaningful growth in 2028.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 98.4%
- Shares Outstanding
- 51.34M
- Float Shares
- 50.51M
of shares held by institutions
399 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for CBT, newest first.
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock, Inc. | 7.05M | ▲ 80.78K |
| Vanguard Group Inc | 5.93M | ▼ 29.70K |
| Earnest Partners LLC | 3.46M | ▲ 113.15K |
| American Century Companies Inc | 3.33M | ▲ 559.49K |
| Vanguard Portfolio Management LLC | 3.08M | ▲ 435 |
| Wellington Management Group Llp | 2.42M | ▼ 1.15M |
| Vanguard Capital Management LLC | 2.32M | ▼ 1.21K |
| State Street Corp | 2.18M | ▲ 10.87K |
| Dimensional Fund Advisors LP | 2.12M | ▲ 195.32K |
| Fuller & Thaler Asset Management, Inc. | 1.83M | ▼ 177.06K |
| Fmr LLC | 1.81M | ▲ 249.17K |
| Geode Capital Management, LLC | 1.77M | ▼ 5.98K |
Held by 482 ETFs
Biggest fund positions in CBT by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 13, 26 | Masterson William F III | other | 3,754 |
| Nov 13, 26 | Masterson William F III | other | 13,815 |
| Nov 13, 26 | Zhu Jeff Ji | other | 5,005 |
| Nov 13, 26 | Zhu Jeff Ji | other | 18,421 |
| Nov 13, 26 | Delahunt Steven J | other | 1,251 |
| Nov 13, 26 | Dumont Lisa M | other | 1,334 |
| Nov 13, 26 | McLaughlin Erica | other | 20,856 |
| Nov 13, 26 | McLaughlin Erica | other | 76,754 |
| Nov 13, 26 | Kalita Karen A | other | 13,815 |
| Nov 13, 26 | Kalita Karen A | other | 3,754 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our CBT coverage
Recent articles, reports, and earnings notes.
No research on CBT yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CBT report →Dividend Champion, Contender, And Challenger Highlights: Week Of November 22
seekingalpha.com · Nov 20
Cabot Corporation Board Declares Dividend
globenewswire.com · Nov 16
Cabot Q4 Earnings Beat on Performance Chemicals Strength
zacks.com · Nov 6
ARQ (NASDAQ:ARQ) versus Cabot (NYSE:CBT) Head-To-Head Survey
defenseworld.net · Nov 5
Cabot Q4 Earnings Call Highlights
marketbeat.com · Nov 3
Cabot Corporation (CBT) Q4 2026 Earnings Call Transcript
seekingalpha.com · Nov 3
Cabot (CBT) Beats Q4 Earnings and Revenue Estimates
zacks.com · Nov 2
Cabot Corporation Reports Fourth Quarter and Fiscal Year 2026 Results
globenewswire.com · Nov 2
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.